Published in J Clin Pathol on November 01, 2005
Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma. World J Gastroenterol (2007) 0.85
Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci (2003) 8.84
Radical causes of cancer. Nat Rev Cancer (2003) 5.45
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature (2003) 3.77
Oxidative stress-related molecules and liver fibrosis. J Hepatol (2001) 2.75
Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res (1994) 1.47
An update on the molecular genetics of hepatocellular carcinoma. Semin Liver Dis (2004) 1.15
Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Genes Chromosomes Cancer (2000) 1.12
Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol (2004) 1.10
Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma. Br J Cancer (1999) 0.95
Differential cellular and subcellular localization of heme-binding protein 23/peroxiredoxin I and heme oxygenase-1 in rat liver. J Histochem Cytochem (2003) 0.93
Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma. Liver Int (2003) 0.91
Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis. Genes Chromosomes Cancer (2005) 0.90
Characterization of mouse peroxiredoxin I genomic DNA and its expression. Gene (1999) 0.85
Pathological significance of oxidative cellular damage in human alcoholic liver disease. Histopathology (2003) 0.84
Allelic imbalance at 1p36 in the pathogenesis of human hepatocellular carcinoma. Hepatogastroenterology (2004) 0.84
An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. Hepatology (2001) 0.84
Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma. Anticancer Res (2004) 0.83
Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma. Mod Pathol (2002) 0.81
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 2.75
JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol (1999) 2.60
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol (2000) 2.05
Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell (2001) 1.79
CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol (1999) 1.67
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65
T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol (1994) 1.62
Characterization of time-related changes after experimental bile duct ligation. Br J Surg (2008) 1.60
The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle. Genes Dev (2001) 1.50
Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene (2000) 1.45
Placental vascularisation requires the AP-1 component fra1. Development (2000) 1.34
Adenosine deaminase deficiency in adults. Blood (1997) 1.15
Correlation of microscopic phenotype with genotype in a formalin-fixed, paraffin-embedded testicular germ cell tumor with universal DNA amplification, comparative genomic hybridization, and interphase cytogenetics. Am J Pathol (1995) 1.13
Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia (2008) 1.08
Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene. Oncogene (2006) 1.03
Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr Relat Cancer (2005) 1.02
Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass. Diabetologia (2010) 1.02
Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am J Pathol (2001) 0.98
p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene. Cell Death Differ (2013) 0.97
Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience. Ann N Y Acad Sci (2006) 0.95
Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions. Gut (2006) 0.92
Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol (1995) 0.88
IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology (2006) 0.88
Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice. Br J Cancer (2007) 0.88
Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression. J Pathol (2001) 0.88
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology (2016) 0.88
VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors. Endocr Relat Cancer (2009) 0.87
Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse. Gut (2006) 0.87
Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas. J Clin Endocrinol Metab (2001) 0.86
Histological evaluation of the adrenal glands of seven dogs with hyperadrenocorticism treated with trilostane. Vet Rec (2007) 0.86
No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma. Endocr Relat Cancer (2005) 0.86
High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. Eur J Cancer (2013) 0.84
[Condylar metastasis. Review of the literature and report of a case]. Mund Kiefer Gesichtschir (2005) 0.81
Analysis of oncogenic AKT1 p.E17K mutation in carcinomas of the biliary tract and liver. Br J Cancer (2008) 0.81
Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1. Bone (2004) 0.81
Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties. J Endocrinol Invest (2004) 0.81
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocr Relat Cancer (2007) 0.80
ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas). Neuroendocrinology (2016) 0.78
[Morphology, DNA cytophotometry and prognosis in gastrointestinal neuroendocrine tumours (carcinoids). A clinico-pathological study of 95 patients]. Pathologe (2000) 0.78
Total removal of a primary intracranial squamous cell carcinoma invading the brain stem. Surg Neurol (1996) 0.77
A model of ischemic isolated acute liver failure in pigs: standardizing monitoring and treatment. Eur Surg Res (2010) 0.77
[The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment]. Pathologe (2010) 0.77
PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas. J Pathol (2006) 0.77
Histomorphological changes after neodymium: YAG laser-coagulation of the human prostate with the Side Focus fiber. Effect of power setting and time. Urol Res (1997) 0.77
Characterization of MENX-associated pituitary tumours. Neuropathol Appl Neurobiol (2013) 0.77
[Preoperative T-staging of prostatic carcinoma: endorectal magnetic resonance tomography compared with other imaging and clinical methods]. Rofo (1996) 0.77
Laser ablation-induced changes in the prostate: findings at endorectal MR imaging with histologic correlation. Radiology (1997) 0.76
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum. Neuroendocrinology (2016) 0.76
[What is new in the pathology of pancreatic neuroendocrine tumors?]. Pathologe (2015) 0.76
An unusual case of a highly progressive supratentorial capillary haemangioblastoma - histopathological considerations. Acta Neurochir (Wien) (2007) 0.75
A case of central alveolar hypoventilation in medullary thyroid cancer. Swiss Med Wkly (2004) 0.75
Lymphangitic carcinomatosis of colon carcinoma: a sign of poor prognosis. Clin Exp Dermatol (2012) 0.75
[Sensory neuronopathy of Sjögren's syndrome. A diagnostic challenge]. Nervenarzt (2012) 0.75
Primary cerebral amyloidoma. Neurology (2001) 0.75
Successful outcome of severe adenovirus hepatitis of the allograft following liver transplantation. Transpl Infect Dis (2007) 0.75
Function of Fos proteins in bone cell differentiation. Bone (1999) 0.75
[Chloral hydrate and diarrhea. A 76-year-old retired administration employee]. Praxis (Bern 1994) (2004) 0.75
[Intratumoral heterogeneity of HER2 status in breast carcinoma]. Pathologe (2010) 0.75
[Gastrin cell hyperplasia associated with duodenal MEN1-related gastrinomas: histopathology and genetics]. Verh Dtsch Ges Pathol (2007) 0.75
An open study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses. Schizophr Res (1991) 0.75
[Adverse internal medicine drug effects at hospital admission]. Schweiz Med Wochenschr (1999) 0.75
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). Br J Cancer (2015) 0.75
Enormous hemangiosarcoma of the heart. Clin Investig (1994) 0.75
[Neuroendocrine neoplasms of the distal jejunum and ileum]. Pathologe (2014) 0.75
[Intrahepatic sarcoma of the follicular dendritic cells]. Pathologe (2010) 0.75
MRI-correlated morphological changes after Nd:YAG laser treatment of the human prostate with the SideFocus fiber. Urol Int (1997) 0.75
[Laser treatment of benign prostatic hypertrophy: the correlation of histologic results to nuclear magnetic resonance imaging]. Ann Urol (Paris) (1997) 0.75
DNA cytophotometry and prognosis in typical and atypical bronchopulmonary carcinoids. A clinicomorphologic study of 100 neuroendocrine lung tumors. Am J Surg Pathol (1996) 0.75